Gao Yi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A stem cell-based bio-artificial liver therapy developed by scientists in China has received approval for clinical trials. Groundbreaking therapy system: The Chinese research team, led by Dr. Gao Yi from the Translational Medicine Centre at Zhujiang Hospital of Southern Medical University, developed the bio-artificial liver system that uses a bioreactor to perform the essential functions of the liver, such as detoxification and protein synthesis, outside the body. Deadly disease: Liver disease is responsible for 4% of all deaths, accounting for 2 million fatalities around the world each year...

Experts say it could potentially reduce the reliance on liver transplants, which come with significant challenges and limitations

The stem cell-based bio-artificial liver has been approved for clinical trials to help liver patients remove toxins from their blood.

Liver failure currently lacks a treatment option with only a transplant a way to improve patient health. A bioartificial liver could change that.

Poor consumer appetite is fueling a price war among lower-end restaurant chains in China, which analysts say could harm smaller businesses struggling to keep up with discounts offered by bigger players